Serum S-adenosylhomocysteine levels are associated with first stroke in Chinese adults with hypertension
Clinica Chimica Acta · 2024
DOI: 10.1016/j.cca.2024.119730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2024. Verfasst von Ziyi Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Stroke, S-Adenosylhomocysteine, Hypertension. Die Arbeit nennt 28 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: The association between S-adenosylhomocysteine (SAH) and stroke has not been confirmed due to the specialized equipment and time requirements necessary for S-adenosylhomocysteine testing. We aimed to explore the association between SAH and stroke. METHODS: A nested, case-control study drawn from the China Stroke Primary Prevention Trial of rural adults with hypertension, including 557 first stroke cases and 557 matched controls was conducted. Serum SAH was measured by stable-isotope dilution liquid chromatography-tandem mass spectrometry using 4500MD. Multiple conditional logistic regression models were used to evaluate the association between SAH and first stroke. RESULTS: In females, SAH levels were significantly higher in the stroke population than in the control group (16.0 ng/mL vs. 14.6 ng/mL). When SAH was assessed as quartiles, the odds of stroke were 1.78 (95 % CI: 1.02-3.09) in Quartile 2, 1.31 (95 % CI: 0.73-2.33) in Quartile 3, and 1.93 (95 % CI: 1.03-3.62) in Quartile 4, compared to Quartile 1. When Quartiles 2-4 were combined, the adjusted odds ratio of first stroke was 1.64 (95 % CI: 1.03-2.62) compared with Quartile 1. In subgroup analysis, a significant SAH-stroke association was observed in the lower vitamin D3 group (OR = 3.35, 95 % CI:1.72-6.53; P interaction, 0.035). In males, higher levels of SAH were associated with an increased risk of stroke in those under age 60. Compared with the reference group, the adjusted odds ratio of total stroke was 2.40 (95 % CI: 1.02-5.91) in the combined group (Quartile 2-4). In contrast, no significant association between SAH and stroke was found in males aged 60 or older. CONCLUSIONS: This study reveals that SAH is associated with a higher risk of stroke independently of homocysteine, especially in females. SAH may be a second predictor of stroke in the metabolic pathway of methionine, after homocysteine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Cardiology, Peking University First Hospital, Beijing, China.
- State Key Laboratory of Natural Medicines, Research Center of Biostatistics and Computational Pharmacy, China Phamaceutical University, Nanjing, China.
- Institute of Biomedicine, Anhui Medical University, Hefei, China.
- Guangdong Key Laboratory of H-type Hypertension and Stroke Precision Prevention Research and Development Enterprise, Shenzhen, China.
- Department of Cardiology, Peking University First Hospital, Beijing, China. Electronic address: lijianping03455@pkufh.com.
Zitieren
APA
Zhou, Z., Zhang, N., Wu, Z., Song, Y., Xu, X., Zhang, Y., Huo, Y., & Li, J. (2024). Serum S-adenosylhomocysteine levels are associated with first stroke in Chinese adults with hypertension. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2024.119730
Vancouver
Zhou Z, Zhang N, Wu Z, Song Y, Xu X, Zhang Y, et al. Serum S-adenosylhomocysteine levels are associated with first stroke in Chinese adults with hypertension. Clinica Chimica Acta. 2024. doi:10.1016/j.cca.2024.119730
BibTeX
@article{Zhou2024,
author = {Zhou, Ziyi and Zhang, Nan and Wu, Zhongyun and Song, Yun and Xu, Xiping and Zhang, Yan and Huo, Yong and Li, Jianping},
title = {Serum S-adenosylhomocysteine levels are associated with first stroke in Chinese adults with hypertension},
journal = {Clinica Chimica Acta},
year = {2024},
doi = {10.1016/j.cca.2024.119730}
}
EUVIMED